JPS6416726A - Production of aspirin dl-lysine injection - Google Patents

Production of aspirin dl-lysine injection

Info

Publication number
JPS6416726A
JPS6416726A JP16855887A JP16855887A JPS6416726A JP S6416726 A JPS6416726 A JP S6416726A JP 16855887 A JP16855887 A JP 16855887A JP 16855887 A JP16855887 A JP 16855887A JP S6416726 A JPS6416726 A JP S6416726A
Authority
JP
Japan
Prior art keywords
solution
cacl2
mgcl2
aspirin
dried
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP16855887A
Other languages
Japanese (ja)
Other versions
JPH0525860B2 (en
Inventor
Osamu Umagoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teysan Pharmaceuticals Co Ltd
Original Assignee
Teysan Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teysan Pharmaceuticals Co Ltd filed Critical Teysan Pharmaceuticals Co Ltd
Priority to JP16855887A priority Critical patent/JPS6416726A/en
Publication of JPS6416726A publication Critical patent/JPS6416726A/en
Publication of JPH0525860B2 publication Critical patent/JPH0525860B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To obtain an injection, by heating and drying a solution of MgCl2 and/or CaCl2 in a lower alcohol as a main component, adding the solution to aspirin DL-lysine powder and (iso)nicotinic acid amide as a stabilizer. CONSTITUTION:A solution of MgCl2 and/or CaCl2 in a lower alcohol (preferably ethanol) as a main component is heated and dried to give a dried solution, which is blended with aspirin DL-lysine powder (one obtained by filtering solution and then lyophilizing) and (iso)nicotinic acid amide as a stabilizer to give the titled injection which is stable after long-term preservation and is rapidly dissolved in use. The solution containing the lower alcohol as the main component is heated and dried at <=5mmHg at 70-120 deg.C in the case of MgCl2 and preferably normal pressure at about 160 deg.C in the case of CaCl2. The content of MgCl2 and/or CaCl2 is preferably 2-10wt.% based on the whole contact.
JP16855887A 1987-07-08 1987-07-08 Production of aspirin dl-lysine injection Granted JPS6416726A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16855887A JPS6416726A (en) 1987-07-08 1987-07-08 Production of aspirin dl-lysine injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16855887A JPS6416726A (en) 1987-07-08 1987-07-08 Production of aspirin dl-lysine injection

Publications (2)

Publication Number Publication Date
JPS6416726A true JPS6416726A (en) 1989-01-20
JPH0525860B2 JPH0525860B2 (en) 1993-04-14

Family

ID=15870254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16855887A Granted JPS6416726A (en) 1987-07-08 1987-07-08 Production of aspirin dl-lysine injection

Country Status (1)

Country Link
JP (1) JPS6416726A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001003774A3 (en) * 1999-07-07 2002-03-21 Zoltan Dardai Pharmaceutical composition for the treatment of calcification
CN102976962A (en) * 2012-11-20 2013-03-20 万红贵 L-ornithine-aspirin double salt and its preparation method and use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001003774A3 (en) * 1999-07-07 2002-03-21 Zoltan Dardai Pharmaceutical composition for the treatment of calcification
CN102976962A (en) * 2012-11-20 2013-03-20 万红贵 L-ornithine-aspirin double salt and its preparation method and use

Also Published As

Publication number Publication date
JPH0525860B2 (en) 1993-04-14

Similar Documents

Publication Publication Date Title
DE3679640D1 (en) EXTRACTION OF LIGNIN.
JPS559023A (en) Production of dopa preparation in high concentration
ATE12162T1 (en) COLD SOLUTION TEA.
DK54081A (en) PROCEDURE FOR THE PREPARATION OF INSULIN DERIVATIVES
GR3004047T3 (en)
JPS6416726A (en) Production of aspirin dl-lysine injection
JPS53125587A (en) Temperature controller
JPS6416799A (en) H-pth (1-34) composition and its preparation
JPS5562005A (en) Skin cosmetic
JPS52128288A (en) Glucose isomerase solution
JPS57192399A (en) Composition containing s-adenosyl-l-methionine and its preparation
JPS54126206A (en) Suppression of heat browning of phospholipids
Tertyshny et al. Effect of orthophosphoric acid on survivability of Propionibacterium shermanii after spray drying and in the process of storage.
JPS5411233A (en) Anitidote
JPS5783550A (en) High polymeric temperature-sensitive material
Laczay et al. Study of the compatibility between monensin and other chemotherapeutics in broilers.
JPS57106610A (en) Preparation of prolonged release type composite
JPS54157815A (en) Anti-tumor substance and its preparation
Amons et al. page 41, column 2, line 6 should read
JPS5543371A (en) High-frequency heater
Tsuji et al. Effect of endotoxin on the lethal toxicity of various environmental pollutants for killifish(Oryzias latipes).
JPS5623891A (en) Stabilization of urokinaze by heating
MOS HEAT BALANCE OF A CHAMBER DRIER
JPS5721315A (en) Stable solid preparation of cytochrome c and its preparation
JPS5484093A (en) Preparation of glutathione-containing liquid